Elyxium Wealth’s IDEAYA Biosciences IDYA Stock Holding History

Elyxium Wealth’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.11K	Buy	+133	New	+$5.02K	﹤0.01%	1167

Other funds holding IDYA

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Park Avenue Securities New York $16.4B AUM 18.52% 1-Year Est. Return

Elyxium Wealth's IDYA Position: Q3 2026 in Review

Elyxium Wealth opened a new position in IDEAYA Biosciences (IDYA) in Q3 2026: 133 shares worth $5.11K. The stake represents ﹤0.01% of the portfolio and ranks #1167 among its holdings.

48 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

Elyxium Wealth held 133 shares of IDEAYA Biosciences worth $5.11K as of Q3 2026.
IDEAYA Biosciences was a new Elyxium Wealth position in Q3 2026.
IDEAYA Biosciences made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #1167 holding.
48 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.